Fiscal year ending 2024. Filed on November 14, 2025.
9 Bedford Street
Burlington, Massachusetts 01803
Neurofibromatosis Inc. Northeast (EIN: 04-3013709) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, Neurofibromatosis Inc. Northeast, a 501(c)(3) charitable organization, reported compensation for 1 out of 8 total employees. Among the employees shown here, the average compensation is $143,049. The highest compensated employee at Neurofibromatosis Inc. Northeast is Sharon Klein with fiscal year 2024 compensation of $143,049.
Revenue
Expenses
Employee compensation
NEUROFIBROMATOSIS, INC. NORTHEAST IS COMMITTED TO ADVANCING RESEARCH INTO THE CAUSES, TREATMENT, AND CURE OF NEUROFIBROMATOSIS. THE ORGANIZATION RAISES FUNDS TO SUPPORT SCIENTIFIC RESEARCH, PROVIDES VITAL SUPPORT SERVICES TO INDIVIDUALS LIVING WITH THE CONDITION AND THEIR FAMILIES, AND HELPS SUSTAIN CLINICS DEDICATED TO THE DIAGNOSIS AND CARE OF NEUROFIBROMATOSIS PATIENTS. THROUGH EDUCATION AND OUTREACH, THE ORGANIZATION ALSO WORKS TO INCREASE PUBLIC AWARENESS AND UNDERSTANDING OF THE DISEASE.
Be the first to know when new IRS Form 990 data is published for this organization.